Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp
Get in touch

Monopoly Rights for Brimonidine Tartrate Drops

High Profit Margins from Chronic Glaucoma Segment

Brimotale Edge: Trusted Ophthalmic Solution

Secure Exclusive Territory in Ophthalmology Segment

Low Investment, Full Technical Marketing Support
Start Your High-Value Ophthalmic Business Today

Home/Products /brimonidine-tartrate-ip-0-2-w-v-eye-drop

Brimonidine Tartrate 0.2% Franchise in Lucknow UP
Brimonidine Tartrate 0.2% Franchise in Lucknow UP
Glaucoma PCD opportunity for Brimotale in Bhopal
Monopoly rights Brimonidine Eye Drop across Odisha
Ophthalmic pharma franchise opportunity in Chandigarh
Brimonidine Tartrate 0.2% Franchise in Lucknow UP
Glaucoma PCD opportunity for Brimotale in Bhopal
Monopoly rights Brimonidine Eye Drop across Odisha
Ophthalmic pharma franchise opportunity in Chandigarh

Brimotale Eye Drops

Brimonidine Tartrate IP 0.2% w/v Eye Drop

Therapeutic Category

Ophthalmology, Antihistamines, Gastroenterology

Dosage Form

Eye Drops

Packaging Type

Dropper

Packaging

5ml

Price

₹1/-

Contact For Enquiry

Therapeutic

Analgesics
Antacid
Antibacterials
Antibiotic
Anticancer
Anticoagulant
Antidepressant
Antidiabetic
Antidiarrheal
Antiepileptic
Antifungals
Antihistamines
Anti-Inflammatories
Antipsychotic
Antipyretics
Antispasmodic
Antiviral
Asthma
Cardiology
Cardiovascular
Cold and Cough
Dental
Depressant
Dermatology
Diabetic
Endocrinology
ENDOCRINOLOGY and Hormonal range
Gastroenterology
General and OTC medicines
Gynecology and Fertility
Hepatology
Hypertension/ Blood Pressure
Immunology
Laxatives
Nephrology
Neurology
Nutraceuticals, Multivitamins and Multiminerals
Oncology
Ophthalmology
Orthopedics
Pediatrics
Pulmonary
Respiratory
Rheumatology
Sedative or Antianxiety
Stimulant
Urology
ENT
Anti Malarial
Andrology
Download Visual

High-resolution images and Product visuals

Watch Video

Product overview and usage information

Read Literature

Detailed information and research documents

About the Product

Description

Brimotale Eye Drops (Brimonidine Tartrate 0.2% w/v) is a high-profit chronic care product built for our PCD Pharma Franchise partners.

This essential alpha-adrenergic agonist is widely used to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Since glaucoma requires lifelong treatment, this product guarantees stable, long-term prescription refills.

Why Brimotale is Your Key to Profit:

  1. Stable, Long-Term Demand: As a cornerstone drug for glaucoma management, Brimotale ensures consistent, recurring revenue based on chronic patient needs, providing financial stability.

  2. Specialty Market Margin: Positioned in the high-value ophthalmic segment, this product commands premium pricing and secures some of the highest profit margins within specialty eye care.

  3. Doctor Loyalty: The established efficacy of Brimonidine Tartrate builds strong prescription loyalty from Ophthalmologists, securing your long-term success.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics. Partner with us for full marketing support and reliable supply to convert this high-value product into guaranteed business growth.

Contact us today to capture this high-margin ophthalmic segment!

Patients may experience injection site discomfort, gastrointestinal upset (nausea, vomiting, diarrhea), rash, or mild liver enzyme elevations. Less commonly, hypersensitivity reactions and hematologic abnormalities such as eosinophilia or neutropenia may occur. Rare instances of C. difficile-associated diarrhea should be considered during prolonged use.

This formulation is used in the treatment of severe systemic infections such as urinary tract infections, lower respiratory tract infections (including pneumonia), intra-abdominal infections, skin and soft tissue infections, gynecological infections, and septicemia caused by susceptible gram-negative bacteria. It is particularly valuable in hospital-acquired infections or polymicrobial infections when used in combination with other antimicrobials.

This injection should only be used under the supervision of a qualified healthcare professional. Renal function should be monitored in long-term or high-dose treatments, and dose adjustment may be required in renal impairment. Aztreonam is not effective against gram-positive or anaerobic organisms, and should be used in combination therapy if mixed infections are suspected.

Store in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Similar Products

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Brimonidine Tartrate IP 0.2% w/v Eye Drops in the PCD pharma franchise market?

Brimonidine Tartrate 0.2% Eye Drops have strong demand in the ophthalmology (glaucoma) segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on chronic eye-care therapies.

Why should medical distributors include Brimonidine Eye Drops in their product range?

Medical distributors and agencies can benefit from consistent long-term demand for management of glaucoma and ocular hypertension, where sustained treatment is required to control intraocular pressure (IOP). Brimonidine reduces aqueous humor production and increases fluid outflow This helps in lowering eye pressure and protecting the optic nerve, strengthening a reliable ophthalmology portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Brimonidine Tartrate 0.2% Eye Drops with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong ophthalmologist prescriptions, chronic disease repeat sales, stable long-term demand, hospital and clinic usage, reliable supply chain support, and good margins in eye-care medicines.

How can I become a distributor or franchise partner for Brimonidine Eye Drops?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited

Links

Contact Us

+91 9518447302
info@cafoli.in
Plot No. 367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

Let's Socialize

Professional B2B Disclaimer: This website is a Business-to-Business (B2B) platform intended exclusively for pharmaceutical traders, distributors, wholesalers, and healthcare professionals. The information provided—including product compositions, therapeutic categories, and portfolios—is for commercial and educational reference only. It is not intended for consumers or as a substitute for professional medical advice, diagnosis, or treatment. Cafoli Lifecare does not sell medicines directly to individuals. All trade inquiries are subject to valid drug license verification.

@2024 | copy rights by Cafoli